Back
Top 0.3%
19.8%
Top 0.1%
19.8%
Top 44%
16.3%
Top 35%
6.6%
#1
5.6%
Top 46%
2.2%
Top 18%
2.2%
Top 7%
2.2%
Top 8%
1.7%
Top 14%
1.3%
Top 17%
1.1%
Top 52%
1.1%
Top 18%
0.8%
Top 19%
0.8%
Top 13%
0.8%
Top 38%
0.5%
Top 5%
0.5%
Top 16%
0.5%
Top 9%
0.5%
Twelve-Month Outcomes of Faricimab for Patients With Sub-optimally Responsive Diabetic Macular Oedema in a UK Tertiary Referral Centre
2024-12-17
ophthalmology
Title + abstract only
View on medRxiv
Show abstract
PurposeEvaluating 12-month visual and anatomical outcomes after switching to faricimab in diabetic macular oedema (DMO) patients with sub-optimal response to aflibercept 2mg. Patients and methodsSixty-two eyes of fifty patients were enrolled in this retrospective study at a UK tertiary referral centre. This consisted of DMO patients with sub-optimal response to aflibercept 2mg who were switched to faricimab. Four loading injections of faricimab were given at monthly intervals, followed by a tre...
Predicted journal destinations
1
Translational Vision Science & Technology
18 training papers
2
Ophthalmology Science
15 training papers
3
PLOS ONE
1737 training papers
4
Scientific Reports
701 training papers
5
F1000Research
28 training papers
6
BMJ Open
553 training papers
7
eLife
262 training papers
8
Journal of Clinical Medicine
77 training papers
9
Cureus
64 training papers
10
npj Digital Medicine
85 training papers
11
Frontiers in Medicine
99 training papers
12
Nature Communications
483 training papers
13
PLOS Digital Health
88 training papers
14
Journal of Medical Internet Research
81 training papers
15
Vaccines
131 training papers
16
JAMA Network Open
125 training papers
17
British Journal of Cancer
22 training papers
18
Frontiers in Immunology
140 training papers
19
International Journal of Molecular Sciences
39 training papers